Company Filing History:
Years Active: 1993-1996
Title: Fredericus A Asselbergs - Innovator in the Field of Pharmaceutical Compositions
Introduction: Fredericus A Asselbergs, a male inventor based in Riehen, Switzerland, has made significant contributions to the field of pharmaceutical compositions through his innovative patents.
Latest Patents:
1. Hybrid Plasminogen Activator: Asselbergs' latest patent involves novel single-chain hybrid plasminogen activators with modified N-glycosylation sites, exhibiting valuable pharmacological properties. These activators are produced using recombinant DNA technology.
2. Pharmaceutical Compositions: Asselbergs' invention focuses on pharmaceutical compositions comprising a combination of two different plasminogen activators for the prophylaxis and therapy of thrombosis.
Career Highlights: Asselbergs is associated with Ciba-Geigy Corporation, a renowned company in the pharmaceutical industry, where he continues to drive innovation through his research and patent filings.
Collaborations: Asselbergs has collaborated with esteemed coworkers such as Jutta Heim and Bhanu Rajput, further enriching the depth of his research and inventions in the field.
Conclusion: Fredericus A Asselbergs' dedication to developing novel pharmaceutical compositions underscores his commitment to advancing the field of medicine. His patents reflect a deep understanding of molecular biology and a relentless pursuit of innovation in healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.